Financial reports
10-Q
2024 Q1
Quarterly report
20 May 24
NT 10-Q
Notice of late quarterly filing
15 May 24
10-K
2023 FY
Annual report
27 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
24 Jul 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
Current reports
8-K
Departure of Directors or Certain Officers
17 Jun 24
8-K
Smartkem Announces Uplisting to Nasdaq
31 May 24
8-K
Smartkem Reports Fourth Quarter and Full Year 2023 Financial Results
28 Mar 24
8-K
Unregistered Sales of Equity Securities
28 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
8-K
Smartkem, Inc. Appoints Melisa a. Denis to the Board of Directors
28 Nov 23
8-K
SMARTKEM, INC. ANNOUNCES 1-for-35 REVERSE STOCK SPLIT
20 Sep 23
8-K
Departure of Directors or Certain Officers
8 Sep 23
8-K
Departure of Directors or Certain Officers
28 Aug 23
8-K
Sri Peruvemba Joins Smartkem Board of Directors
18 Jul 23
Registration and prospectus
8-A12B
Registration of securities on exchange
30 May 24
424B3
Prospectus supplement
20 May 24
424B3
Prospectus supplement
20 May 24
424B3
Prospectus supplement
20 May 24
424B3
Prospectus supplement
17 Apr 24
424B3
Prospectus supplement
17 Apr 24
S-8
Registration of securities for employees
11 Apr 24
S-1
IPO registration
11 Apr 24
POS AM
Prospectus update (post-effective amendment)
11 Apr 24
424B3
Prospectus supplement
10 Apr 24
Other
CERT
Certification of approval for exchange listing
30 May 24
EFFECT
Notice of effectiveness
18 Apr 24
EFFECT
Notice of effectiveness
18 Apr 24
EFFECT
Notice of effectiveness
10 Apr 24
EFFECT
Notice of effectiveness
31 Jul 23
UPLOAD
Letter from SEC
26 Jul 23
CORRESP
Correspondence with SEC
25 Jul 23
EFFECT
Notice of effectiveness
11 Apr 23
EFFECT
Notice of effectiveness
8 Sep 22
EFFECT
Notice of effectiveness
8 Sep 22